13 research outputs found
Anemia in patients with type 1 diabetes mellitus
Aim. To study the prevalence and structure of anemia syndrome in patients with type 1 diabetes mellitus (DM1) in Tatarstan. Materials and methods. Population-based screening studies for decreased blood Hb level were carried out in the cities of Kazan, Nabereznye Chelny,Chistopol and in the Arsk district. A total of 567 DM1 patients were involved; medical histories of 846 patients (54% of those registered in Kazan)were analysed. All patients were examined to elucidate the causes behind the reduced Hb level.Results and conclusions. Two screening techniques revealed anemia in 27 and 34% of the patients compared with 20% in the general population. Itsfrequency was estimated at 13% in the Arsk district. Anemia occurred more frequently in women than in men. The blood Hb level was directly relatedto GFR and inversely related to the presence of chronic renal disease and DM1 duration. Anemia of chronic disease (ACD) and iron deficiency anemia(IDA) prevailed in the structure of anemia syndrome in DM1 patients. These conditions accounted for 85.5% of all cases of anemia). IDA predominatedin patients without clinical manifestations of DN and in those with DN and preserved renal function while ACD associated with DN and impairedrenal function. Almost every third case of anemia was a combination of ACD and IDA. Folic acid deficiency was unrelated to the renal functio
Excretion of amine nitrogen and ammonia in urine of pregnant women with type 1 diabetes mellitus
Aim.
To study excretion of amine nitrogen and ammonia in urine of pregnant women with type 1 diabetes mellitus depending on gestational ageand albuminuria level.
Materials and methods.
A total of 60 pregnant women with type 1 diabetes mellitus were examined. Proximal and distal tubular function was estimatedfrom daily excretion of amine nitrogen and ammonia respectively.
Results.
Daily excretion of amine nitrogen and ammonia in urine of pregnant women with type 1 diabetes mellitus was lower than in healthycontrols in the 2nd trimester regardless of albuminuria and in the 3rd trimester in patients with microalbuminuria (MAU) and proteinuria (PU).Ammonia excretion was twice lower than normal in the 2nd trimester in women with MAU and PU, and in the 3rd trimester in patients with PU.Healthy pregnant women showed significant correlation between ammonia and amine nitrogen excretion throughout pregnancy (r?0.833,
Diagnosis of diabetic autonomous cardioneuropathy in patients with type 1 diabetes mellitus
Autonomous cardiac neuropathy is a diabetic complication characterized by early disseminated sympathetic and parasympathetic small-fiber neuronaldegeneration. Prevalence, pathogenesis, risk factors, clinical manifestations, and early diagnosis of pathology are discussed
The incidence of anemia syndrome in patients with type 1 diabetes mellitus in the city of Kazan
Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ Π°Π½Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π 1 ΡΠΈΠΏΠ° (Π‘Π1) Π² Π Π΅ΡΠΏΡΠ±Π»ΠΈΠΊΠ΅ Π’Π°ΡΠ°ΡΡΡΠ°Π½ (Π Π’). ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π Π³. ΠΠ°Π·Π°Π½ΠΈ Π±ΡΠ»ΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½ΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΡΠ±ΠΎΡΠΊΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π1, ΠΏΡΠΈΡΠ΅Π΄ΡΠΈΡ
Π½Π° Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΡΠΉ ΠΏΡΠΈΠ΅ΠΌ ΠΈ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΡ
Π½Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ°Ρ
Π°ΡΠ° ΠΊΡΠΎΠ²ΠΈ Π² Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΡ. ΠΠ° 1 ΠΌΠ΅ΡΡΡ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΡΡ 1 151 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ, ΠΈΠ· Π½ΠΈΡ
ΠΎΠΊΠ°Π·Π°Π»ΠΎΡΡ 252 Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π1. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π°Π½Π΅ΠΌΠΈΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π1 Π² Π³. ΠΠ°Π±Π΅ΡΠ΅ΠΆΠ½ΡΠ΅ Π§Π΅Π»Π½Ρ, Π³. Π§ΠΈΡΡΠΎΠΏΠΎΠ»Ρ ΠΈ ΠΡΡΠΊΠΎΠΌ ΡΠ°ΠΉΠΎΠ½Π΅ Π Π’ ΠΈΠ·ΡΡΠ°Π»Π°ΡΡ ΠΏΡΡΠ΅ΠΌ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΡΠΏΠ»ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³Π°, ΡΡΠ΅Π΄ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π1 ΠΠ°Π·Π°Π½ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½Π½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π° Π±ΡΠ» Π²ΡΡΠ²Π»Π΅Π½ Ρ 69 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ ΠΈΠ· 252 ΡΠΊΡΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
(27%), ΡΡΠΎ ΠΏΡΠ΅Π²ΡΡΠ°Π΅Ρ ΠΎΠΆΠΈΠ΄Π°Π΅ΠΌΡΡ ΡΠ°ΡΡΠΎΡΡ Π² ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ 20%. Π‘ΡΠ΅Π΄ΠΈ ΠΆΠ΅Π½ΡΠΈΠ½ ΡΠ½ΠΈΠΆΠ΅Π½Π½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π° Π²ΡΡΡΠ΅ΡΠ°Π»ΡΡ ΡΠ°ΡΠ΅, ΡΠ΅ΠΌ ΡΡΠ΅Π΄ΠΈ ΠΌΡΠΆΡΠΈΠ½. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΡΡ
ΠΊΠ°ΡΡ, Π² 420 ΠΈΠ· 846 (50%) ΠΏΡΠΎΡΠΌΠΎΡΡΠ΅Π½Π½ΡΡ
ΡΡΠΎΠ²Π΅Π½Ρ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΡΡ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΡ
ΡΡΠ΅Ρ
Π»Π΅Ρ, ΠΈ Π² 74 ΠΈΠ· 846 (9%) Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 2009 Π³. Π 25 ΠΈΠ· 74 (34%) ΠΊΠ°ΡΡΠ°Ρ
Π±ΡΠ» Π²ΡΡΠ²Π»Π΅Π½ ΡΠ½ΠΈΠΆΠ΅Π½Π½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°, ΡΡΠΎ ΡΠ°ΠΊΠΆΠ΅ Π±ΠΎΠ»ΡΡΠ΅ ΠΎΠΆΠΈΠ΄Π°Π΅ΠΌΡΡ
20%. ΠΡΠ²ΠΎΠ΄Ρ. Π§Π°ΡΡΠΎΡΠ° Π°Π½Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΏΡΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠΈ Π΄Π²ΡΡ
ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΡΠΊΡΠΈΠ½ΠΈΠ½Π³Π° Π² Π³. ΠΠ°Π·Π°Π½ΠΈ ΠΎΠΊΠ°Π·Π°Π»Π°ΡΡ Π±ΠΎΠ»ΡΡΠ΅ (27% ΠΈ 34%), ΡΠ΅ΠΌ Π² ΡΡΠ΅Π΄Π½Π΅ΠΌ Π² ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π (20%). Π£ ΠΆΠ΅Π½ΡΠΈΠ½ Π°Π½Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ Π²ΡΡΡΠ΅ΡΠ°Π΅ΡΡΡ ΡΠ°ΡΠ΅, ΡΠ΅ΠΌ ΡΡΠ΅Π΄ΠΈ ΠΌΡΠΆΡΠΈΠ½. Π£ΡΠΎΠ²Π΅Π½Ρ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π° Π² ΠΊΡΠΎΠ²ΠΈ Π½Π°Ρ
ΠΎΠ΄ΠΈΡΡΡ Π² ΠΏΡΡΠΌΠΎΠΉ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΡΠΎΠ²Π½Ρ Π‘ΠΠ€ ΠΈ ΠΎΠ±ΡΠ°ΡΠ½ΠΎΠΉ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΡΠ°Π΄ΠΈΠΈ Π₯ΠΠ ΠΈ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π‘Π
Kidneys cytomembranes stability in pregnant women with type 1 diabetes and pregnancy outcomes depending on the method of insulin delivery
Objective.
To evaluate of kidney cytomembranes stability during pregnancy and its outcomes in patients with diabetes mellitus type on type 1 with different stages of diabetic nephropathy (DN) according to the route of insulin administration.
Materials and Methods.
We study 100 pregnant women with type 1 diabetes with the introduction of insulin in the mode of multiple subcutaneous injections (MSII) and with portable dispenser with a continuous subcutaneous insulin infusion (CSII). DN stage determined by the level of albumin in the daily urine. Cytomembranes stability assessment conducted on daily excretion of ethanolamine and phospholipids with urine in each trimester. Pregnancy outcomes were analyzed in 52 patients with type 1 diabetes. In the group of pregnant women with delivery at term 38-40 weeks we also analyzed the status of newborns.
Results.
Indicators of cytomembranes stability of kidneys in pregnant women on CSII consistent with those in healthy pregnant women (p>0.05) the whole pregnancy, regardless of the level of daily urinary albumin excretion. There were no differences in cytomembrana stability of kidneys between the group of patients on MSII with normal albumin excretion (NAU) and the control group regardless to the gestational age (p>0.05). With the introduction of insulin in the mode of MSII on the stage of microalbuminuria (MAU) in the 3rd trimester we found the increase of ethanolamine excretion as compared to control groupy (U=8,00, p=0.012) and the group on CSII with a similar stage of nephropathy (U=2.00, p=0.033). In patients with proteinuria (PU) in the group on the MSII in the third trimester phospholipids excretion is increased with a daily urine (U=27,5, p=0.03 and U=22,00, p=0.07 for patients MSII and CSII, respectively). The use of an insulin pump allowed to prolong gestational period, even in severe proteinuric stage of nephropathy. Manifestations of diabetic fetopathy as macrosomia, hypoglycemia in the fetus at birth time mothers using CSII mode were less common than with MSII (p=0.01 and p=0.04, respectively). In the CSII group no resuscitation was needed, as opposed to 20% of children whose mothers used the MSII.
Conclusion.
The administration of insulin using portable dispenser the of mode CSII during pregnancy in patients with type 1 diabetes, even at the initial stage of the DN the cytomembranes stability is saved, pregnancy outcomes are improved
Skorost' Na/Li-npomueompaHcnopma v eritrotsitakh u bol'nykh sakharnym diabetom tipa 1 i razvitie diabeticheskoy nefropatii
Π¦Π΅Π»Ρ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΊΠΎΡΠΎΡΡΠΈ Na/Li-ΠΠ’ Π² ΡΡΠΈΡΡΠΎΡΠΈΡΠ°Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π ΡΠΈΠΏΠ° 1 Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ ΡΡΠ°Π΄ΠΈΠΈ ΠΠ ΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π΅Π³ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ Π²Π»ΠΈΡΠ½ΠΈΡ Π½Π° ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π΅ΡΡΠΎΠΏΠ°ΡΠΈΠΈ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ 131 Π±ΠΎΠ»ΡΠ½ΠΎΠΉ Π‘Π ΡΠΈΠΏΠ° 1. ΠΡΠ΅ Π±ΠΎΠ»ΡΠ½ΡΠ΅ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈΡΡ ΠΏΠΎ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠ΅, ΠΊΠΎΡΠΎΡΠ°Ρ ΠΏΡΠ΅Π΄ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅Ρ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ½ΡΡΡΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΡΠΎΠ½ΠΈΡΠ°Π΅ΠΌΠΎΡΡΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ Π΄Π»Ρ Π½Π°ΡΡΠΈΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΊΠΎΡΠΎΡΡΠΈ Na/Li-ΠΠ’ Ρ Π²ΡΠ΅Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π ΡΠΈΠΏΠ° 1 ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΡΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΠΌΠΈ Π»ΠΈΡΠ°ΠΌΠΈ. ΠΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ΅ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ Na/Li-ΠΠ’ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΠΌ ΡΡΠΎΠ²Π½Π΅ΠΌ Π²ΡΡΠ²Π»Π΅Π½Ρ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΌΠΈΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠ΅ΠΉ ΠΈ ΠΌΠ°ΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠ΅ΠΉ. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΌΠΈΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠ΅ΠΉ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ΅ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΊΠΎΡΠΎΡΡΠΈ Na/Li-ΠΠ’ ΠΏΠΎΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠΎΠ»ΡΠΊΠΎ ΠΏΡΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π‘Π Π±ΠΎΠ»Π΅Π΅ 10 Π»Π΅Ρ. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
, Ρ ΠΊΠΎΡΠΎΡΡΡ
ΠΌΠ°ΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΡ ΡΠ°Π·Π²ΠΈΠ»Π°ΡΡ Π½Π° ΡΠ°Π½Π½ΠΈΡ
ΡΡΠ°Π΄ΠΈΡΡ
Π‘Π (Π΄ΠΎ 10 Π»Π΅Ρ), ΡΠΊΠΎΡΠΎΡΡΡ Na/Li-ΠΠ’ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠ°Ρ, ΡΠ΅ΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΌΠ°ΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ 10 Π»Π΅Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. ΠΡΠ²ΠΎΠ΄Ρ. Π‘ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΊΠΎΡΠΎΡΡΠΈ Na/Li-ΠΠ’ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΠ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π΅Ρ. ΠΠΎΠ»ΡΠ½ΡΠ΅ Ρ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΠΌΠΈ Π·Π½Π°ΡΠ΅Π½ΠΈΡΠΌΠΈ Na/Li-ΠΠ’ Π² ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠΈ Ρ Π΄ΡΡΠ³ΠΈΠΌΠΈ ΠΏΡΠΎΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌΠΈ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌΠΈ ΠΈΠΌΠ΅ΡΡ ΡΠ°Π½Ρ ΡΠΎΡ
ΡΠ°Π½ΠΈΡΡ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ ΡΡΠ½ΠΊΡΠΈΡ ΠΏΠΎΡΠ΅ΠΊ Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ Π΄ΠΎΠ»Π³ΠΎΠ΅ Π²ΡΠ΅ΠΌΡ. ΠΠΎΠ»ΡΠ½ΡΠ΅ Ρ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΠΌΠΈ ΡΠΈΡΡΠ°ΠΌΠΈ Na/Li-ΠΠ’ ΠΈΠΌΠ΅ΡΡ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π΄ΠΈΠ°Π±Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½Π΅ΡΡΠΎΠΏΠ°ΡΠΈΠΈ Π½Π° ΡΠ°Π½Π½ΠΈΡ
ΡΡΠΎΠΊΠ°Ρ
ΡΠ΅ΡΠ΅Π½ΠΈΡ Π‘Π
Risk factors for diabetic autonomic cardiovascular neuropathy in children and adolescents with type 1 diabetes mellitus
Aim.
To determine risk factors for diabetic autonomic cardiovascular neuropathy (DACN) and to optimize diagnostic procedures forΒ children and adolescents with type 1 diabetes mellitus.
Materials and methods.
Heart rate variability (HRV) was assessed in 101 subjects with type 1 diabetes mellitus aged 5?17 y.o.Β in 4 functional tests. Subjects with 3 positive tests out 4 were considered positive for DACN.
Results.
Increased glycemic variability (9+ mmol/l per day), regular hypoglycemic events and late diabetes complications were found to be DACN risk factors in children and adolescents.
Conclusions.
A diagnostic algorithm for DACN in children and adolescents with type 1 diabetes mellitus based on orthostatic HRV variability assessment shows high sensitivity and efficiency
Ekskretsiya fosfolipidov s mochoy u bol'nykh diabeticheskoy nefropatiey
Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠΈΡΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠ°Ρ
Π°ΡΠ½ΡΠΌ Π΄ΠΈΠ°Π±Π΅ΡΠΎΠΌ (Π‘Π) 1 ΡΠΈΠΏΠ° ΡΠΊΡΠΊΡΠ΅ΡΠΈΡ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² Ρ ΠΌΠΎΡΠΎΠΉ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° Π³Π»ΠΈΠΊΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ, ΡΡΠ°Π΄ΠΈΠΈ Π΄ΠΈΠ°Π±Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½Π΅ΡΡΠΎΠΏΠ°ΡΠΈΠΈ ΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΎ 113 Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π 1 ΡΠΈΠΏΠ° (75 ΠΆΠ΅Π½ΡΠΈΠ½ ΠΈ 38 ΠΌΡΠΆΡΠΈΠ½) Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 18 Π΄ΠΎ 68 Π»Π΅Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ ? 37,23 ? 1.21), Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π²Π°ΡΡΠΈΡΠΎΠ²Π°Π»Π° ΠΎΡ 1 ΠΌΠ΅Ρ Π΄ΠΎ 35 Π»Π΅Ρ (Π² ΡΡΠ΅Π΄Π½Π΅ΠΌ 13,59 + 0,8 Π»Π΅Ρ). ΠΠ°ΡΡΠΈΠ°Π»ΡΠ½ΡΠ΅ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΏΠΎΡΠ΅ΠΊ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈΡΡ ΠΏΠΎ Π²Π΅Π»ΠΈΡΠΈΠ½Π΅ ΠΊΠ»ΡΠ±ΠΎΡΠΊΠΎΠ²ΠΎΠΉ ΡΠΈΠ»ΡΡΡΠ°ΡΠΈΠΈ. ΠΡΠ΅Π½ΠΊΠ° ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΠΈ ΡΠΈΡΠΎΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΠΏΠΎ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² ΡΡΡΠΎΡΠ½ΠΎΠΉ ΠΌΠΎΡΠΈ. Π ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ Π³ΡΡΠΏΠΏΡ Π²ΠΎΡΠ»ΠΈ 24 Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡΠ°. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΊΡΠΊΡΠ΅ΡΠΈΠΈ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² Ρ ΠΌΠΎΡΠΎΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π 1 ΡΠΈΠΏΠ° ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΡΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΠΌΠΈ. ΠΠΊΡΠΊΡΠ΅ΡΠΈΡ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² Ρ ΠΌΠΎΡΠΎΠΉ ΠΏΠΎΠ²ΡΡΠ°Π΅ΡΡΡ Ρ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΠΌΠΈΠΊΡΠΎΡΠΎΡΡΠ΄ΠΈΡΡΡΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π² ΠΏΠΎΡΠΊΠ°Ρ
. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΌΠΈΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠ΅ΠΉ ΡΠΊΡΠΊΡΠ΅ΡΠΈΡ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² Ρ ΠΌΠΎΡΠΎΠΉ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 1,03?0,4 ΠΌΠΌΠΎΠ»Ρ/Π» ΠΈ Π·Π°Π²ΠΈΡΠ΅Π»Π° ΠΎΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΈΠΈ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π°. ΠΡΠ²ΠΎΠ΄Ρ. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π ΠΏΠΎΠ²ΡΡΠ΅Π½Π° ΡΠΊΡΠΊΡΠ΅ΡΠΈΡ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² Ρ ΠΌΠΎΡΠΎΠΉ Π² ΡΠΎΡΡΠΎΡΠ½ΠΈΠΈ Π΄Π΅ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΈΠΈ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π°, Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ Π΄Π°Π²Π½ΠΎΡΡΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΏΠΎΡΠ΅ΠΊ. ΠΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΈΡ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΡΡΠΈΠΈ ΡΠΎΠ»ΡΠΊΠΎ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π½ΠΎΡΠΌΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠ΅ΠΉ Ρ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ Π‘Π ΠΌΠ΅Π½Π΅Π΅ 5 Π»Π΅Ρ. ΠΡΠΈ Π΄Π°Π²Π½ΠΎΡΡΠΈ Π΄ΠΈΠ°Π±Π΅ΡΠ° ΠΎΡ 5 Π΄ΠΎ 15 Π»Π΅Ρ ΡΠΊΡΠΊΡΠ΅ΡΠΈΡ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² Π½Π°ΡΠ°ΡΡΠ°Π΅Ρ ΠΏΠΎ ΠΌΠ΅ΡΠ΅ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½Π΅ΡΡΠΎΠΏΠ°ΡΠΈΠΈ ΠΈ Π½Π΅ ΡΠ½ΠΈΠΆΠ°Π΅ΡΡΡ ΠΏΡΠΈ ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΈΠΈ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π°. ΠΡΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΈ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΏΠΎΡΠ΅ΠΊ ΡΠΊΡΠΊΡΠ΅ΡΠΈΡ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠΈΠ΄ΠΎΠ² Ρ ΠΌΠΎΡΠΎΠΉ ΡΠΏΠΎΠ½ΡΠ°Π½Π½ΠΎ ΡΠ½ΠΈΠΆΠ°Π΅ΡΡΡ, Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΈΠΈ Π΄ΠΈΠ°Π±Π΅ΡΠ°
Epidemiologicheskie issledovaniya sakharnogo diabeta s ispol'zovaniem mobil'nogo nauchno-issledovatel'skogo i lechebnogo tsentra
Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π‘Π ΠΈ ΠΎΡΠ΅Π½ΠΊΠ° ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΏΠΎΠΌΠΎΡΠΈ Π±ΠΎΠ»ΡΠ½ΡΠΌ Π² ΡΡΠ΄Π΅ ΡΠ΅Π³ΠΈΠΎΠ½ΠΎΠ² Π ΠΎΡΡΠΈΠΈ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π° Π²ΡΠ±ΠΎΡΠΊΠ° 730 Π±ΠΎΠ»ΡΠ½ΡΡ
, ΠΊΠΎΡΠΎΡΠ°Ρ Π²ΠΊΠ»ΡΡΠ°Π»Π° Π΄Π΅ΡΠ΅ΠΉ, ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΈ Π²Π·ΡΠΎΡΠ»ΡΡ
. ΠΡΠΎΠ³ΡΠ°ΠΌΠΌΠ° ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π²ΠΊΠ»ΡΡΠ°Π»Π° ΡΠΈΠ·ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠ΅ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ, ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΎΡΠ³Π°Π½ΠΎΠ² Π·ΡΠ΅Π½ΠΈΡ, ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ, ΠΏΠΎΡΠ΅ΠΊ, Π½ΠΈΠΆΠ½ΠΈΡ
ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΡΡΠ΅ΠΉ. Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΎΡΡ ΠΏΠΎ ΡΡΠΎΠ²Π½Ρ ΠΠ²Π1Ρ, ΡΡΠ½ΠΊΡΠΈΡ ΠΏΠΎΡΠ΅ΠΊ ? ΠΏΠΎ ΡΡΠΎΠ²Π½Ρ ΠΊΡΠ΅Π°ΡΠΈΠ½ΠΈΠ½Π°, ΠΌΠΎΡΠ΅Π²ΠΈΠ½Ρ Π² ΠΊΡΠΎΠ²ΠΈ, Π½Π°Π»ΠΈΡΠΈΡ ΠΌΠΈΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠΈ ΠΈ ΠΏΡΠΎΡΠ΅ΠΈΠ½ΡΡΠΈΠΈ; Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° - ΠΏΠΎ ΡΡΠΎΠ²Π½Ρ ΠΎΠ±ΡΠ΅Π³ΠΎ Ρ
ΠΎΠ»Π΅ΡΡΠ΅ΡΠΈΠ½Π° ΠΈ ΡΡΠΈΠ³Π»ΠΈΡΠ΅ΡΠΈΠ΄ΠΎΠ². Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ Π΄ΠΈΠ°Π±Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½Π΅ΡΡΠΎΠΏΠ°ΡΠΈΠΈ ΡΡΠ΅Π΄ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π 2 ΡΠΈΠΏΠ° Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΠΏΡΠ΅Π²ΡΡΠ°Π»ΠΈ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΠ΅ΠΌΡΡ Ρ ΠΌΡΠΆΡΠΈΠ½ Π² 5 ΡΠ°Π·, Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Π² 3 ΡΠ°Π·Π°. ΠΡΠΈ 1 ΡΠΈΠΏΠ΅ Π‘Π ΡΠ°ΠΊΡΠΈΡΠ΅?
ΡΠΊΠ°Ρ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π΄ΠΈΠ°Π±Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠ°ΡΠ°ΡΠ°ΠΊΡΡ, ΠΏΠΎΠ»ΠΈΠ½Π΅ΠΉΡΠΎΠΏΠ°ΡΠΈΠΈ ΠΏΡΠ΅Π²ΡΡΠ°Π΅Ρ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΠ΅ΠΌΡΡ Π² 2 ΡΠ°Π·Π°, Π΄ΠΈΠ°Π±Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠΎΠΏΡ Π½Π° ? 30%, Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΠΈ Π² 2,5 ΡΠ°Π·Π°. ΠΠ½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΡ Π΄ΠΎΠ»Ρ (11,34%) ΡΠΎΡΡΠ°Π²Π»ΡΡΡ Π±ΠΎΠ»ΡΠ½ΡΠ΅ Ρ ΡΡΠΆΠ΅Π»ΡΠΌΠΈ ΠΈΡΡ
ΠΎΠ΄Π°ΠΌΠΈ ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ: ΡΠ»Π΅ΠΏΠΎΡΠ° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ 1 ΡΠΈΠΏΠΎΠΌ Π‘Π Π΄ΠΎΡΡΠΈΠ³Π°Π΅Ρ 2,47%, Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠ³ΠΎ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π‘Π 2 ΡΠΈΠΏΠ° ? 8,9%. Π£ Π΄Π΅ΡΠ΅ΠΉ Ρ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ Π‘Π ΡΠΈΠΏΠ° 1 Π½Π΅ Π±ΠΎΠ»Π΅Π΅ 2 Π»Π΅Ρ Π΄ΠΈΡΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Π΅ΠΌΠΈΡ Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ Ρ 2,2%, ΡΡΠ΅Π΄ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ? 9,2%, Π° Ρ Π²Π·ΡΠΎΡΠ»ΡΡ
ΡΠΎ Π‘Π ΡΠΈΠΏΠ° 2 ? 39,2%. ΠΡΠ²ΠΎΠ΄Ρ. Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ Π»Π΅ΡΠ΅Π±Π½ΠΎ-ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π² ΡΠ΅ΡΠΏΡΠ±Π»ΠΈΠΊΠ΅ Π’Π°ΡΠ°ΡΡΡΠ°Π½ ΡΡΠ΅Π±ΡΠ΅Ρ ΠΏΡΠΈΠ½ΡΡΠΈΡ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΌΠ΅Ρ ΠΏΠΎ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π΄ΠΈΠ°Π±Π΅ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ. Π§ΠΈΡΠ»ΠΎ Π±ΠΎΠ»ΡΠ½ΡΡ
, Π½Π°Ρ
ΠΎΠ΄ΡΡΠΈΡ
ΡΡ Π² ΡΠΎΡΡΠΎΡΠ½ΠΈΠΈ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄Π΅ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΈΠΈ Π΄ΠΈΠ°Π±Π΅ΡΠ°, ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ ΠΎΡ 18,1% Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ Π²Π·ΡΠΎΡΠ»ΡΡ
Π΄ΠΎ 41,5% Ρ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ². Π ΡΠ΅Π»ΠΎΠΌ ΠΏΠΎ ΡΠ΅ΡΠΏΡΠ±Π»ΠΈΠΊΠ΅ Π±ΠΎΠ»ΡΠ½ΡΠ΅ Π½Π΅ ΠΏΠΎΠ»ΡΡΠ°ΡΡ Π² Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΠΌ ΠΎΠ±ΡΠ΅ΠΌΠ΅ ΠΏΠΎΠΌΠΎΡΠΈ ΡΠ°ΠΊΠΈΡ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ², ΠΊΠ°ΠΊ ΠΎΡΡΠ°Π»ΡΠΌΠΎΠ»ΠΎΠ³, ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³, Π½Π΅Π²ΡΠΎΠΏΠ°ΡΠΎΠ»ΠΎΠ³, Π½Π΅ΡΡΠΎΠ»ΠΎΠ³ ΠΈ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡ ΠΏΠΎ Π΄ΠΈΠ°Π±Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠΎΠΏΠ΅?. Π Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π‘Π ΡΠΈΠΏΠ° 2 Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΡΠΈΡΠ΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ ΠΈΠ½ΡΡΠ»ΠΈΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ
History of the development of endocrinology in the Republic of Tatarstan
May 14, 2014 marks 200 years since the establishment of the Medical Department of the Imperial Kazan University (now Kazan State Medical University, KSMU). Since the XIX century, scientists of the Kazan Medical School studied physiology and pathology of the endocrine system. The first researchers were interested in the problems of endemic goitre, diabetes mellitus, and function of the adrenal glands. In 1976, the Endocrinology Department was organised in the Kazan State Medical Institute, the first among universities of the RSFSR. The head of the Department, V.V. Talantov, became the chief non-staff endocrinologist of the Ministry of Health of the Republic of Tatarstan (RT) and organiser of the Association of Endocrinologists in the RT. Moreover, he contributed to the organisation of the endocrine service in the republic and endocrinology began to be taught as an independent discipline. V.V. Talantov was a member of the Scientific Council of Endocrinology of the Russian Academy of Medical Sciences, Deputy Chairman of the Committee of Endocrinology Problems of the Ministry of Health, and a member of the editorial boards of four medical journals. The research in the field of endocrinology is now actively continued on the endocrinology course at KSMU. In-depth study of various aspects of the pathogenesis of diabetes and its complications was selected as the first-priority